T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FCE.A
601
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $128M | 0.02% |
5,095,201
+1,434,909
| +39% | +$35M |
|
|
AIMT
602
DELISTED
Aimmune Therapeutics
AIMT
| $128M | 0.02% |
4,685,457
+31,516
| +0.7% | +$891K |
|
603
McCormick & Company Non-Voting
MKC
$14.6B
| $128M | 0.02% |
1,939,218
-43,312
| -2% | -$2.67M |
|
604
Ryanair
RYAAY
$30.9B
| $127M | 0.02% |
3,313,198
+202,395
| +7% | +$8.33M |
|
|
GWR
605
DELISTED
Genesee & Wyoming Inc.
GWR
| $127M | 0.02% |
1,393,019
-14,581
| -1% | -$1.27M |
|
606
FIVE9
FIVN
$2.35B
| $127M | 0.02% |
2,898,087
-708,866
| -20% | -$29.2M |
|
607
Heritage Financial
HFWA
$1.23B
| $126M | 0.02% |
3,593,034
+305,844
| +9% | +$11M |
|
608
VeriSign
VRSN
$25.7B
| $126M | 0.02% |
788,140
+9,180
| +1% | +$1.41M |
|
|
BNCL
609
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $125M | 0.02% |
7,384,574
+96,037
| +1% | +$1.64M |
|
|
NBIS
610
Nebius Group N.V.
NBIS
$74.7B
| $123M | 0.02% |
3,754,517
+92,518
| +3% | +$3.13M |
|
611
Pebblebrook Hotel Trust
PEB
$2.04B
| $123M | 0.02% |
3,382,082
-180,297
| -5% | -$6.88M |
|
|
EBSB
612
DELISTED
Meridian Bancorp, Inc.
EBSB
| $121M | 0.02% |
7,110,432
+697,319
| +11% | +$12.7M |
|
|
ALDR
613
DELISTED
Alder Biopharmaceuticals
ALDR
| $120M | 0.02% |
7,222,584
+5,359,871
| +288% | +$96.9M |
|
614
Constellation Brands
STZ
$23.3B
| $120M | 0.02% |
556,599
-57,405
| -9% | -$12.2M |
|
|
KMG
615
DELISTED
KMG Chemicals Inc
KMG
| $119M | 0.02% |
1,579,792
-767,188
| -33% | -$57.2M |
|
616
CubeSmart
CUBE
$9.42B
| $117M | 0.02% |
4,108,548
+601,240
| +17% | +$18.4M |
|
617
PTC Therapeutics
PTCT
$6.04B
| $117M | 0.02% |
2,492,785
+1,824,417
| +273% | +$75.5M |
|
618
Cognex
CGNX
$10.2B
| $117M | 0.02% |
2,097,253
+705,594
| +51% | +$36.2M |
|
619
Lennar Class A
LEN
$21.1B
| $117M | 0.02% |
2,582,800
-553,075
| -18% | -$27.9M |
|
|
IBTX
620
DELISTED
Independent Bank Group, Inc.
IBTX
| $117M | 0.02% |
1,760,749
-15,614
| -0.9% | -$1.07M |
|
|
TGI
621
DELISTED
Triumph Group
TGI
| $116M | 0.02% |
4,970,883
+405,263
| +9% | +$8.48M |
|
622
Lumen
LUMN
$6.43B
| $115M | 0.02% |
5,405,096
-1,051,276
| -16% | -$22M |
|
623
Helios Technologies
HLIO
$2.65B
| $115M | 0.02% |
2,090,287
-84,465
| -4% | -$4.28M |
|
|
HMSY
624
DELISTED
HMS Holdings Corp.
HMSY
| $114M | 0.02% |
3,476,044
-252,077
| -7% | -$7.29M |
|
625
Mueller Water Products
MWA
$4.07B
| $114M | 0.02% |
9,875,838
+1,782,434
| +22% | +$21.1M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.